✦ LIBER ✦

Voriconazole as primary antifungal prophylaxis in patients with neutropenia after hematopoietic stem cell transplantation or chemotherapy for acute myeloid leukemia

✍ Scribed by Antonio Torres; Josefina Serrano; Rafael Rojas; Vanesa Martín; Carmen Martín; Salvador Tabares; José R. Molina; Manuel Capote; Francisco Martínez; Pedro Gómez; Joaquín Sánchez-García

Book ID: 114794692
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 69 KB
Volume: 84
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.2009.01367.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictable prognostic factor of CD56 ex

Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation

✍ Deok-Hwan Yang; Je-Jung Lee; Yeung-Chul Mun; Ho-Jin Shin; Yeo-Kyeoung Kim; Sang- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

The superiority of haploidentical relate

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission

✍ Huang, X.-J.; Zhu, H.-H.; Chang, Y.-J.; Xu, L.-P.; Liu, D.-H.; Zhang, X.-H.; Jia 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 316 KB

Myeloablative Reduced-Toxicity i.v. Busu

Myeloablative Reduced-Toxicity i.v. Busulfan-Fludarabine and Allogeneic Hematopoietic Stem Cell Transplant for Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome in the Sixth through Eighth Decades of Life

✍ Gheath Alatrash; Marcos de Lima; Nelson Hamerschlak; Matteo Pelosini; Xuemei Wan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Reduced-toxicity conditioning with treos

Reduced-toxicity conditioning with treosulfan, fludarabine and ATG as preparative regimen for allogeneic stem cell transplantation (alloSCT) in elderly patients with secondary acute myeloid leukemia (sAML) or myelodysplastic syndrome (MDS)

✍ Kröger, N; Shimoni, A; Zabelina, T; Schieder, H; Panse, J; Ayuk, F; Wolschke, C; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 153 KB

356: First line sequential therapy with

356: First line sequential therapy with intensive consolidation chemotherapy and allogeneic hematopoietic stem cell transplantation (ASCT) after reduced intensity conditioning (RIC) for patients with acute myeloblastic leukemia (AML) in first complete remission (CR1)

✍ D. Blaise; R. Tabrizi; C. Faucher; M. Mohty; J.O. Bay; J.M. Boiron; G. Marit; S. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Comparative Outcomes of Donor Graft CD34

Comparative Outcomes of Donor Graft CD34+ Selection and Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis for Patients With Acute Myeloid Leukemia in Complete Remission Undergoing HLA-Matched Sibling Allogeneic Hematopoietic Cell Transplantation

✍ Pasquini, M. C.; Devine, S.; Mendizabal, A.; Baden, L. R.; Wingard, J. R.; Lazar 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 162 KB